Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-22-060225

SVP, CFO & Treasurer sold 4,792 shares at $10.61 ($50,827)

  • SVP, CFO & Treasurer acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Moran Kevin Patrick · SVP, CFO & Treasurer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-06 Exercise or conversion : show line 1 in the form +7,500 $3.12 $23,400 124,952 D
2022-12-06 Sale : show line 2 in the form −4,792 $10.61 $50,827 120,160 D
Open-market sales · 4,792 sh · avg $10.61 · $50,827

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-12-06 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −7,500 0 D
Loading xslF345X03/doc4.xml…